Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001178913-25-002810
Filing Date
2025-08-12
Accepted
2025-08-12 16:19:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 zk2533628.htm 424B3 1372448
2 image00001.jpg GRAPHIC 588870
  Complete submission text file 0001178913-25-002810.txt   2184638
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284873 | Film No.: 251207007
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)